Previous Statements by MYL
» Mylan's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Mylan, Inc. - Analyst/Investor Day
» Mylan's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Here's what moving in the world of Biotech
The result was due largely to a 'just vote no' campaign against the directors.
The company's chairman and director received stiff investor opposition at the company's annual shareholder meeting last week.